The overarching AITL subgroup was associated with a unique spectrum of mutations consisting of TET2, IDH2, DNMT3A, RHOA, CD28, as well as gene fusions such as ITK-SYK or CTLA4-CD28. The gene discussed is IDH2; the disease is angioimmunoblastic T-cell lymphoma.